Paper Details

  1. Home
  2. Paper Details

Evaluation of "Gastromiro" for bowel opacification during computed tomography: comparison with diatrizoate and barium sulphate.

Author: DoyleG J, KeirM J, McDonaldJ R, MurthyL N, O'DonnellS C, WrightA R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A new oral formulation of iopamidol, 'Gastromiro', was evaluated as a bowel contrast agent during abdominal computed tomography (CT) and compared to existing agents.
Paper Details　
Original Abstract of the Article :
A new oral formulation of iopamidol, "Gastromiro", was evaluated as a bowel contrast agent during abdominal computed tomography (CT). Comparison was made with the well established agents sodium/meglumine diatrizoate ("Urografin 370") and dilute barium sulphate ("E-Z CAT") in a randomized, blind stud...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1259/0007-1285-66-788-681

データ提供：米国国立医学図書館（NLM）

Comparing Bowel Contrast Agents for Computed Tomography

Imagine needing a CT scan to get a clear picture of your digestive system, but the contrast agent you use impacts the results. This study evaluated a new oral formulation of iopamidol, 'Gastromiro', as a bowel contrast agent for CT scans, comparing its performance to two well-established agents: sodium/meglumine diatrizoate ('Urografin 370') and dilute barium sulfate ('E-Z CAT'). The researchers conducted a randomized, blind study of 150 patients to assess the effectiveness, side effects, and cost of each contrast agent. The goal was to identify the best contrast agent for visualizing the bowel during CT scans.

'Gastromiro' Shows Promise as a Bowel Contrast Agent

The study found that 'Gastromiro' performed comparably to the established contrast agents in opacifying the stomach and small bowel. While 'E-Z CAT' was found to be more effective at opacifying the caecum and ascending colon, there were no significant differences in overall performance or side effects. However, 'Gastromiro' offered a cost advantage over the other agents.

Informed Decision-Making for Medical Imaging

This study provides valuable insights for physicians and patients choosing a bowel contrast agent for CT scans. It emphasizes the importance of considering factors like cost, effectiveness, and potential side effects when making these decisions. Just as a camel chooses its path through a desert, it's essential to be informed and make choices that align with your individual needs and preferences.

Dr.Camel's Conclusion

This study highlights the importance of continuous research and innovation in the field of medical imaging. The development of new contrast agents like 'Gastromiro' can improve the accuracy and efficiency of CT scans, ultimately leading to better diagnostic outcomes for patients. The study reminds us that choosing the right tools for the job is critical in ensuring successful outcomes in healthcare.

Date :
  1. Date Completed 1995-05-19
  2. Date Revised 2016-11-23
Further Info :

Pubmed ID

7719680

DOI: Digital Object Identifier

10.1259/0007-1285-66-788-681

Related Literature

Article Analysis
・Side Effects of barium sulfate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.